Drug intelligence / Profile preview

Effaclar

Development stage
Unknown
Lead developer
La Roche-Posay
Modality
Small Molecules
Administration
Topical
01

Overview

Effaclar is a brand of dermatological skincare products developed by La Roche-Posay (a division of L'Oréal) specifically for oily and acne-prone skin. The product line includes various formulations, most notably Effaclar Duo (marketed as Effaclar Duo+ in some regions), which is an FDA-approved over-the-counter (OTC) acne treatment in the United States. The US formulation typically contains 5.5% micronized benzoyl peroxide and 0.4% lipo-hydroxy acid (LHA), while global versions often feature a combination of salicylic acid, LHA, niacinamide, and zinc PCA. These active ingredients work synergistically to provide antimicrobial action against *Cutibacterium acnes*, keratolytic effects to clear clogged pores, and anti-inflammatory benefits to reduce redness and swelling associated with acne vulgaris.

Brand names
EffaclarEffaclar DuoEffaclar Duo+Effaclar K+Effaclar MatEffaclar Gel
Other names
Effaclar Acne CreamEffaclar DuoEffaclar K

Beyond the preview

Go deeper on Effaclar.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Effaclar.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call